Overview of Dr. Evering
Dr. Teresa Evering is an infectious disease specialist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. She received her medical degree from Weill Cornell Medicine and has been in practice 20 years. She is one of 142 doctors at New York-Presbyterian Hospital and one of 142 doctors at New York-Presbyterian Hospital who specialize in Infectious Disease. She has more than 30 publications and over 500 citings.
Office
455 1st Ave
7th Floor
New York, NY 10016
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 2000 - 2004
Icahn School of Medicine at Mount Sinai (New York Eye and Ear Infirmary at Mount Sinai)Residency, Otolaryngology - Head and Neck Surgery, 1998 - 2002
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1997 - 2000
Weill Cornell MedicineClass of 1997
Certifications & Licensure
NY State Medical License 2000 - 2025- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 35 citationsCaspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID.Matthew Plassmeyer, Oral Alpan, Michael J. Corley, Thomas A. Premeaux, Kimberleigh Lillard
Allergy. 2021-05-15 - 25 citationsCharacterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccineSteven C. Derrick, Teresa H. Evering, Vasan K. Sambandamurthy, Kripa V. Jalapathy, Tsungda Hsu
Immunology. 2007-02-01 - 26 citationsPostacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.Aluko A Hope, Teresa H Evering
Infectious Disease Clinics of North America. 2022-06-01
Press Mentions
Search Continues for a Treatment That Reduces Long COVID SymptomsOctober 17th, 2024- Trial Evaluates Monoclonal Antibodies for Lengthy COVID PreventionOctober 17th, 2024
- Trial Shows Strong COVID Protection in Antibody CombinationApril 25th, 2023
- Join now to see all
